Home
>
National Drug Code (NDC)
>
MAMONDE BRIGHTENING PACT 10HR N21
MAMONDE BRIGHTENING PACT 10HR N21 - 43419-546-86 - (OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE)
Drug Information of MAMONDE BRIGHTENING PACT 10HR N21
| Product NDC: | 43419-546 |
| Proprietary Name: | MAMONDE BRIGHTENING PACT 10HR N21 |
| Non Proprietary Name: | OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE |
| Active Ingredient(s): | .032; .055; .02 g/g; g/g; g/g & nbsp; OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MAMONDE BRIGHTENING PACT 10HR N21
| Product NDC: | 43419-546 |
| Labeler Name: | AMOREPACIFIC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20101001 |
Package Information of MAMONDE BRIGHTENING PACT 10HR N21
| Package NDC: | 43419-546-86 |
| Package Description: | 16 g in 1 JAR (43419-546-86) |
NDC Information of MAMONDE BRIGHTENING PACT 10HR N21
| NDC Code | 43419-546-86 |
| Proprietary Name | MAMONDE BRIGHTENING PACT 10HR N21 |
| Package Description | 16 g in 1 JAR (43419-546-86) |
| Product NDC | 43419-546 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE |
| Dosage Form Name | POWDER |
| Route Name | TOPICAL |
| Start Marketing Date | 20101001 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | AMOREPACIFIC |
| Substance Name | OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE |
| Strength Number | .032; .055; .02 |
| Strength Unit | g/g; g/g; g/g |
| Pharmaceutical Classes |
